Results 151 to 160 of about 11,011 (206)

Prescriber adherence to asthma treatment guidelines and its impact on symptom control in Ethiopia: a mixed-methods study. [PDF]

Ther Adv Respir Dis
Assefa AN, Alemu MA, Tadesse TY, Aklog AT, Tarekegn GY, Moges TA, Dagnew SB.   +6 more
europepmc   +1 more source

Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study. [PDF]

Pulm Ther
Figueira-Gonçalves JM, Alcázar-Navarrete B, Casitas-Mateo R, González J, Gotera-Rivera CM, Herrejón-Silvestre A, Margallo-Iribarnegaray J, Martín-Lana M, Pallarés-Sanmartín A, Pascual-Guardia S, Saura-Vinuesa A, Corregidor-García C, Fitas E, Sánchez-Covisa J.   +13 more
europepmc   +1 more source

In silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients with COPD Using Functional Respiratory Imaging [Letter]. [PDF]

Int J Chron Obstruct Pulmon Dis
Zambelli E, Warner L, Richards J, Malone R, Piraino A.   +4 more
europepmc   +1 more source

Adverse event mining for Breztri and Trelegy Ellipta based on the three international pharmacovigilance databases. [PDF]

Medicine (Baltimore)
Wang J, Chen K, Yun L, Xu D.
europepmc   +1 more source

Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients

Respiratory Medicine, 2005
SummaryWe conducted a randomized, crossover trial with tiotropium 18μg once daily (group A), and formoterol 12μg twice daily (group B) over a 5-day period for each drug, with a 10-day washout, in 20 COPD patients.
Mario Cazzola, Paolo Noschese, Antonello Salzillo   +2 more
exaly   +2 more sources

Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD

Pulmonary Pharmacology and Therapeutics, 2004
Formoterol is a b2-agonist bronchodilator that combines a fast onset of action with a long duration of broncholytic effect. An increasing documentation is showing that the combination of a long acting b2-adrenoceptor agonist bronchodilator and an ...
Pierachille Santus, Fabiano Di Marco, P Carlucci   +2 more
exaly   +2 more sources

Bronchodilator response to formoterol Turbuhaler in patients with COPD under regular treatment with formoterol Turbuhaler

Pulmonary Pharmacology and Therapeutics, 2003
Formoterol Turbuhaler has been suggested for as-needed use in asthmatic patients. We investigated whether regular treatment with formoterol would modify the dose-response curves to formoterol in patients with partially reversible COPD. In this randomised,
Mario Cazzola, Maria Gabriella Matera, G D'Amato   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Radiation Sterilization of Formoterol

Pharmaceutical Research, 1997
Radiation sterilization is becoming increasingly popular for the sterilization of many pharmaceutical products. We have investigated the gamma radiation induced effects on formoterol fumarate by HPLC and ESR spectroscopy.Numerical simulation of the evolution of the ESR signal versus dose was performed using linear regression, quadratic fit and power ...
J P, Basly, I, Longy, M, Bernard
openaire   +2 more sources

The development of a radioimmunoassay for formoterol

Life Sciences, 1983
The development of a radioimmunoassay (RIA) for the beta 2-stimulant formoterol is described. The sensitivity of the method is 0.1 ng/ml in plasma and urine, when a 1-ml sample is used. The cross-reactivity of the antiserum with formoterol glucuronide was 30%.
K, Yokoi, K, Murase, Y, Shiobara
openaire   +2 more sources